Inogen, Inc (INGN) News
Filter INGN News Items
INGN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
INGN News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest INGN News From Around the Web
Below are the latest news stories about INOGEN INC that investors may wish to consider to help them evaluate INGN as an investment opportunity.
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance DeviceINGN announces FDA clearance for the SIMEOX 200 Airway Clearance Device. |
Inogen Expands U.S. Market with FDA ClearanceThe latest announcement is out from Inogen ( (INGN) ). Inogen, Inc. announced that it has received FDA 510(k) clearance for its Simeox 200 device, designed to enhance airway clearance and improve bronchial drainage for patients with chronic respiratory diseases. The clearance allows Inogen to expand its market reach in the U.S. and requires the company to make a $13 million milestone payment as part of a previous agreement. This development signifies a step forward in Inogen’s efforts to introdu |
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance deviceThe company plans to initiate a limited launch of the device in targeted regions next year. |
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance DeviceGOLETA, Calif., December 30, 2024--Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device |
Here's Why You Should Retain Inogen Stock in Your Portfolio NowExpanding product portfolio and high prospects for POC raise optimism for INGN stock. |
Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78%Key Insights Significantly high institutional ownership implies Inogen's stock price is sensitive to their trading... |
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and InogenIntuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog. |
5 Medical Device Stocks That Survived the 2024 Market VolatilityHere, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which gained in 2024 despite ongoing challenges and provide an attractive investment opportunity for 2025. |
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowInogen (INGN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. |
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin UpInogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales. |